Connect with our CSO, Hugh Salter, to learn more about Anocca’s TCR-T cell therapy technologies, platforms and pipelines.
Press release Sep 8, 2021Anocca appoints Jacob Michlewicz as CFO
Södertälje, Sweden, 8 September 2021 – Anocca AB, a leader in unlocking the potential of …
Press release Sep 8, 2021Anocca utser Jacob Michlewicz till CFO
Södertälje, 8 september 2021 – Anocca AB, ett världsledande svenskt bioteknikbolag för utveckling av T-cellsbehandlingar …
Press release Jul 22, 2021Anocca raises $47m in a Series B Financing to advance its industrialised approach to TCR-T cellular immunotherapy
Södertälje, Sweden, 22 July 2021 – Anocca AB, a leader in unlocking the potential of …